⇀ Investment Team
Founding Partner (Paris)
Pierre is an experienced healthcare manager and deal maker.
He is the former CEO of Urgo and the former CEO of Fournier Pharma. He transformed Urgo into a global wound care giant, increasing revenue from €30m to €700m through a mix of innovation and accretive M&A. He scaled Fournier’s commercial capabilities in the United States and sold the business to Solvay for €1.3bn (excluding earnouts). Pierre began his career as a finance instructor and healthcare merchant banker at Paribas.
He is Chairman Emeritus of the Industry Association MedTech in France and is a graduate of HEC Paris.
Founding Partner (Paris)
Samuel is a physician entrepreneur.
He started his career as a management consultant at McKinsey & Company in New York before moving to Boston to attend Harvard Medical School. As a second-year medical student, Samuel co-founded Allurion Technologies and built a fully-integrated, global medical device company from the idea stage to commercialization in more than 30 countries.
Samuel is a graduate of Yale College (summa cum laude) and Harvard Medical School. He was a Fulbright Scholar to France at the Pasteur Institute.
Founding Partner (San Francisco)
Alex is a healthcare specialist investor.
After starting his career as a management consultant at McKinsey & Company in Boston, he joined Maverick Capital’s healthcare team. Alex focused on long/short public equity and venture capital/cross-over investments, ultimately as Managing Director. Alex then joined Jackson Square Partners where he focused on high-conviction healthcare public equities and led the firm’s ESG activities.
Alex is a graduate of Harvard College (magna cum laude, Phi Beta Kappa).
Edoardo is a professional investor with more than 10 years in private equity.
He started his career at Idinvest focusing on minority equity deals and secondary transactions. Subsequently, Edoardo joined BlackFin Capital Partners where he led the execution of several deals and actively participated in portfolio management and value creation efforts. He then joined Eurazeo where he leveraged his expertise in deal origination and execution and enriched his sectorial knowledge through his involvement in several verticals (Medtech, financial services, TMT).
Edoardo graduated from ESCP, City University London and the University of Turin.
Senior Investment Advisor (Paris)
Nicolas is a decorated private equity investor with more than 30 years of experience.
He started his career doing R&D at Sanofi and research at the Pasteur Institute and Harvard University (as a Tower Fellow). Nicolas transitioned from research to the Private Equity industry holding senior positions first at Electra and then at Cinven. Over more than twenty years, Nicolas led the French team and was part of the Investment Committee and Steering Committee.
Nicolas holds an MBA from INSEAD as well as an MSc in Molecular Biology from ENS Paris.
Senior Associate (Paris)
Before joining Lauxera Capital Partners as a Senior Associate, Charles Cornevin worked at Eurazeo as an Senior Associate.
Charles joined Eurazeo in 2017 as an Analyst after several experiences in M&A and Private Equity (Rothschild and Hudson Advisors / Lone Star Funds in Munich, Dublin and London).
Charles started his career as a generalist investor within Eurazeo Mid-Cap team and has participated in the monitoring of the following investments: Odealim (incl. exit), Redspher, Dessange, and Rosa Group.
He then launched the Eurazeo Healthcare dedicated strategy from scratch and completed two investments in 2021: Novair Group and PSIH.
Charles graduated from Paris Dauphine University – Master Corporate Finance and Financial Engineering.
Charlotte started her career as one of the first 30 employees at French HealthTech unicorn Doctolib, helping doctors to engage with and use the product. Charlotte transitioned into consulting working for more than two years at Parisian healthcare-focused strategy consulting firm FSNB. Charlotte then concretized her interest in finance through an internship at PAI Partners in the Private Equity Group before joining Lauxera in July 2020.
Charlotte graduated with a Master in Management from ESSEC Business School in 2019, after earning a Business Law degree from Panthéon Assas University.
Ruben began his career as a summer intern at EY before interning at Natixis Partners in the M&A Group. In the past, he also worked for a Franco-African think tank for which he published a report on technology entrepreneurship in an emerging economy. Ruben joined Lauxera’s team in January 2020, first as an intern and then as an investment analyst.
Ruben graduated in 2021 with a dual Master in Corporate Management and Public Affairs from HEC Paris and Sciences Po Paris, having earned a dual Bachelor’s degree from Sciences Po Paris and UC Berkeley.
Head of Operations (Paris)
Lise began her career in Molecular Biology research in various institutes before joining Sanofi at the Research and Development (R&D) department. Lise then took her R&D experience to CIMI (Immunology and Infectious Diseases center) in Paris where she conducted research in Cell Therapies in Immunology. Subsequently, she acted as a consultant in Healthcare & Life Sciences at EY before joining Lauxera as the Head of Operations in June 2021.
Lise earned a Doctorate in Pharmacy and a Specialised Master in Innovative Therapies and Biotechnologies from the Université Paris-Sud (Paris XI) before graduating from the ESCP Business School with a Master in Pharmaceutical Management and Biotechnology in 2019.
Office & Events Manager (Paris)
Camille began her career as a projects and events manager in various companies including Natixis and Candriam. She subsequently joined Lauxera as the Office & Events Manager in May 2021.
Camille earned a Master in Management from Ecole International Tunon after having earned a Bachelor’s in communication from the Sorbonne University.